Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier

There is an urgent and unmet need to develop effective therapies for triple negative breast cancers (TNBCs) which are much more aggressive and have poor prognosis due to lack of receptor targets for Her2-targeted and endocrine therapy. In this study we systematically evaluated the effect of Vorinost...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Theranostics
Asıl Yazarlar: Ma, Weina, Sun, Jingjing, Xu, Jieni, Luo, Zhangyi, Diao, Dingwei, Zhang, Ziqian, Oberly, Patrick J., Minnigh, Margaret Beth, Xie, Wen, Poloyac, Samuel M, Huang, Yi, Li, Song
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ivyspring International Publisher 2020
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7052901/
https://ncbi.nlm.nih.gov/pubmed/32194813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.38973
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller